Significance of serum chromogranin-A in patients withliver cirrhosis and hepatocellular carcinoma

Hepatoma-specific AFP (H-S AFP) in the diagnosis of hepatocellular carcinoma

Angiogenic factors mediated plasminogen activators in patients with chronic liver diseases and hepatocellular carcinoma

Angiogenic factors mediated plasminogen activators in patients with chronic liver diseases and hepatocellular carcinoma

significance of endoglin (CD105) concentrations in serum of patients with liver cirrhosis and patients with hepatocellular carcinoma

Clinlcal significance of transforming growth factor-beta1 in the diagnosis of hepatocellular carcinoma associated with hcv infection

Activity of serum angiotensin-converting enzyme as a tumor marker of hepatocellular carcinoma

Expression of hepatocyte paraffin 1 antibody and vascular endothelial growth factor in hepatocellular carcinoma and chronic viral hepatitis : An immunohistochemcial study

Evaluation of annexin II and follistatin as potential serum markers for hepatocellular carcinoma

Serum LINE-1 hypomethylation as diagnostic marker for hepatocellular carcinoma